We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.76B
1-Year Est. Return 62.41%
This Fund
S&P 500
This Quarter Est. Return
+9.09%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$5.62B
AUM Growth
+$874M
Cap. Flow
+$401M
Cap. Flow %
7.12%
Top 10 Hldgs %
66.07%
Holding
710
New
128
Increased
146
Reduced
103
Closed
149
Avg Time Held Equity + Options
3.9 quarters
Top 10 Avg Time Held Equity + Options
1.5 quarters
Top 20 Avg Time Held Equity + Options
1.3 quarters
Avg Time Held Equity only
4.1 quarters
Top 10 Avg Time Held Equity only
1.5 quarters
Top 20 Avg Time Held Equity only
1.3 quarters

Top Buys

Rank Stock Value
1
ATVI
Activision Blizzard
ATVI
+$779M
2
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$358M
3
NEWR
New Relic, Inc.
NEWR
+$258M
4
DEN
Denbury Inc.
DEN
+$175M
5
VMW
VMware, Inc
VMW
+$165M

Top Sells

Rank Stock Value
1
ISEE
IVERIC bio, Inc. Common Stock
ISEE
+$230M
2
PDCE
PDC Energy, Inc.
PDCE
+$221M
3
UNVR
Univar Solutions Inc.
UNVR
+$219M
4
FOCS
Focus Financial Partners Inc. Class A
FOCS
+$146M
5
SYNH
Syneos Health, Inc. Class A Common Stock
SYNH
+$141M

Sector Composition

Rank Sector Weight
1 Technology 39.86%
2 Healthcare 28.77%
3 Miscellaneous 7.24%
4 Real Estate 5.15%
5 Financials 4.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
ALNY icon
501
PUT
Alnylam Pharmaceuticals
ALNY
$31.1B
$14.3K ﹤0.01%
+10,000
New +$1.91M
2023 Q3
0 quarters
ALTUW
502
DELISTED
Altitude Acquisition Corp Warrant
ALTUW
$12.7K ﹤0.01%
231,102
– –
2021 Q1
10 quarters
BIOSW
503
DELISTED
BioPlus Acquisition Corp. Warrants
BIOSW
$12.7K ﹤0.01%
182,071
– –
2022 Q1
6 quarters
SEPAW icon
504
DELISTED
SEP Acquisition Corp Warrants
SEPAW
$11.7K ﹤0.01%
117,263
– –
2022 Q4
3 quarters
CZR icon
505
CALL
Caesars Entertainment
CZR
$6.01B
$11.6K ﹤0.01%
+10,000
New +$531K
2023 Q3
0 quarters
AMSC icon
506
CALL
American Superconductor
AMSC
$1.48B
$11.4K ﹤0.01%
+30,500
New +$253K
2023 Q3
0 quarters
FSRXW
507
DELISTED
FinServ Acquisition Corp. II Warrant
FSRXW
$11.3K ﹤0.01%
305,055
– –
2022 Q1
6 quarters
TVGNW icon
508
Tevogen Inc Warrant
TVGNW
$1.25M
$8.99K ﹤0.01%
186,593
– –
2022 Q1
6 quarters
TBCPW
509
DELISTED
Thunder Bridge Capital Partners III Inc. Warrant
TBCPW
$8.92K ﹤0.01%
138,065
– –
2021 Q2
9 quarters
JTAIW icon
510
DELISTED
Jet.AI Inc. Warrant
JTAIW
$8.9K ﹤0.01%
197,427
– –
2022 Q3
4 quarters
SEDA.WS icon
511
DELISTED
SDCL EDGE Acquisition Corporation Redeemable warrants, each whole warrant exercisable for one share of Class A ordinary share at an exercise price of $11.50
SEDA.WS
$8.89K ﹤0.01%
71,043
– –
2022 Q1
6 quarters
PUCKW icon
512
DELISTED
Goal Acquisitions Corp. Warrant
PUCKW
$8.78K ﹤0.01%
283,281
– –
2021 Q2
9 quarters
COOLW icon
513
DELISTED
Corner Growth Acquisition Corp. Warrant
COOLW
$8.75K ﹤0.01%
109,287
– –
2021 Q1
10 quarters
ENERR
514
DELISTED
Accretion Acquisition Corp Right
ENERR
$8.49K ﹤0.01%
97,876
– –
2021 Q4
7 quarters
BSLKW
515
DELISTED
Bolt Projects Holdings Warrant
BSLKW
$7.47K ﹤0.01%
165,963
– –
2022 Q1
6 quarters
SLACW
516
DELISTED
Social Leverage Acquisition Corp I Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
SLACW
$7.34K ﹤0.01%
128,141
– –
2022 Q1
6 quarters
JWSM.WS icon
517
DELISTED
Jaws Mustang Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
JWSM.WS
$6.85K ﹤0.01%
172,581
– –
2021 Q2
9 quarters
SUAC.WS
518
DELISTED
ShoulderUp Technology Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
SUAC.WS
$5.92K ﹤0.01%
288,877
– –
2023 Q2
1 quarter
FNVTW icon
519
DELISTED
Finnovate Acquisition Corp. Warrants
FNVTW
$5.87K ﹤0.01%
130,406
– –
2021 Q4
7 quarters
NIRWW
520
DELISTED
Near Intelligence, Inc. Warrant
NIRWW
$5.67K ﹤0.01%
225,128
– –
2021 Q1
10 quarters
APXIW icon
521
DELISTED
APx Acquisition Corp. I Warrant
APXIW
$5.24K ﹤0.01%
91,439
– –
2022 Q1
6 quarters
SLRN icon
522
CALL
DELISTED
ACELYRIN
SLRN
$4.71K ﹤0.01%
+14,500
New +$308K
2023 Q3
0 quarters
DISAW
523
DELISTED
Disruptive Acquisition Corporation I Warrant
DISAW
$4.62K ﹤0.01%
84,138
– –
2021 Q2
9 quarters
BURU.WS icon
524
DELISTED
Nuburu, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50
BURU.WS
$4.49K ﹤0.01%
230,109
– –
2021 Q1
10 quarters
IFIN.WS icon
525
DELISTED
InFinT Acquisition Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per whole share
IFIN.WS
$4.36K ﹤0.01%
115,551
– –
2022 Q1
6 quarters
19 20
21
22 23

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return
JCM
Janney Capital Management Pittsburgh, Pennsylvania $1.59B AUM 23.25% 1-Year Est. Return
MPM
Meritage Portfolio Management Overland Park, Kansas $1.51B AUM 26.61% 1-Year Est. Return

UBS O'Connor's Q3 2023 Portfolio in Review

As of Q3 2023, UBS O'Connor held 710 positions worth $5.62B, up 18% from $4.75B the previous quarter. Its ten largest holdings account for 66% of the portfolio.

UBS O'Connor deployed $401M of net new capital in Q3 2023, opening 128 new positions and adding to 146 existing holdings. Its largest new stake was Denbury Inc.: 1,931,731 shares worth $189M.

By sector, the portfolio is most concentrated in Technology at 40% of assets, up from 16% a quarter earlier, followed by Healthcare and Miscellaneous.

On the sell side, the largest reduction was Seagen Inc. Common Stock, an estimated $19.7M trimmed.

  • UBS O'Connor's largest Q3 2023 buy was Denbury Inc.: 1,931,731 shares worth $189M.
  • UBS O'Connor added most to Activision Blizzard in Q3 2023, an estimated $779M increase.
  • UBS O'Connor's biggest Q3 2023 reduction was Seagen Inc. Common Stock, cutting an estimated $19.7M.
  • UBS O'Connor fully exited IVERIC bio, Inc. Common Stock in Q3 2023, selling an estimated $230M.
  • UBS O'Connor's ten largest holdings make up 66% of its $5.62B portfolio in Q3 2023.
  • UBS O'Connor opened 128 new positions and closed 149 in Q3 2023.
  • UBS O'Connor's portfolio value rose 18% quarter-over-quarter to $5.62B.

Based on UBS O'Connor's 13F filing for Q3 2023, filed 14 Nov 2023.